Tsz K. Fung, Ph.D. - Publications

Affiliations: 
2006 Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong 
Area:
Cell Biology

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Luo H, Zhu G, Xu J, Lai Q, Yan B, Guo Y, Fung TK, Zeisig BB, Cui Y, Zha J, Cogle C, Wang F, Xu B, Yang FC, Li W, et al. HOTTIP lncRNA Promotes Hematopoietic Stem Cell Self-Renewal Leading to AML-like Disease in Mice. Cancer Cell. PMID 31786140 DOI: 10.1016/J.Ccell.2019.10.011  0.341
2019 Luo H, Zhu G, Fung TK, Qiu Y, Xu M, So CWE, Huang S. Hottip Lncrna Reinforces CTCF Defined Chromatin Boundaries and Drives Wnt Target Gene Expression in AML Leukemogenesis Blood. 134: 277-277. DOI: 10.1182/Blood-2019-127323  0.364
2019 Fung TK, Zeisig B, Zarowiecki M, Luo H, Tsai CT, Stanojevic B, Lynn C, Leung AY, Zuna J, Zaliova M, Bornhaeuser M, Von Bonin M, Lenhard B, Huang S, Mufti GJ, et al. Reconstruction of Human AML Reveals Stem Cell Origin and Therapeutic Targets for Treatment Resistant CD34-/Lo MLL-Rearranged Leukemia Blood. 134: 3203-3203. DOI: 10.1182/Blood-2019-125078  0.337
2017 Siriboonpiputtana T, Zeisig BB, Zarowiecki M, Fung TK, Mallardo M, Tsai CT, Lau PNI, Hoang QC, Veiga P, Barnes J, Lynn C, Wilson A, Lenhard B, So CWE. Transcriptional memory of cells of origin overrides β-catenin requirement of MLL cancer stem cells. The Embo Journal. PMID 28978671 DOI: 10.15252/Embj.201797994  0.321
2016 Cheung N, Fung TK, Zeisig BB, Holmes K, Rane JK, Mowen KA, Finn MG, Lenhard B, Chan LC, So CW. Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia. Cancer Cell. 29: 32-48. PMID 26766589 DOI: 10.1016/J.Ccell.2015.12.007  0.361
2015 Esposito MT, Zhao L, Fung TK, Rane JK, Wilson A, Martin N, Gil J, Leung AY, Ashworth A, Eric So CW. Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors. Nature Medicine. PMID 26594843 DOI: 10.1038/Nm.3993  0.382
2015 Man CH, Fung TK, Wan H, Cher CY, Fan A, Ng N, Ho C, Wan TS, Tanaka T, So CW, Kwong YL, Leung AY. Suppression of SOX7 by DNA methylation and its tumor suppressor function in acute myeloid leukemia. Blood. 125: 3928-36. PMID 25940713 DOI: 10.1182/Blood-2014-06-580993  0.399
2013 Fung TK, So CWE. Overcoming treatment resistance in acute promyelocytic leukemia and beyond Oncotarget. 4: 1128-1129. PMID 23934744 DOI: 10.18632/Oncotarget.1244  0.359
2012 Fung TK, Gandillet A, So CW. Selective treatment of mixed-lineage leukemia leukemic stem cells through targeting glycogen synthase kinase 3 and the canonical Wnt/β-catenin pathway. Current Opinion in Hematology. 19: 280-6. PMID 22525581 DOI: 10.1097/Moh.0B013E3283545615  0.345
2012 Man CH, Fung TK, Ho C, Han HH, Chow HC, Ma AC, Choi WW, Lok S, Cheung AM, Eaves C, Kwong YL, Leung AY. Sorafenib treatment of FLT3-ITD(+) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation. Blood. 119: 5133-43. PMID 22368270 DOI: 10.1182/Blood-2011-06-363960  0.344
2011 Ma AC, Fung TK, Lin RH, Chung MI, Yang D, Ekker SC, Leung AY. Methionine aminopeptidase 2 is required for HSC initiation and proliferation. Blood. 118: 5448-57. PMID 21937698 DOI: 10.1182/Blood-2011-04-350173  0.331
2011 Chung MI, Ma AC, Fung TK, Leung AY. Characterization of Sry-related HMG box group F genes in zebrafish hematopoiesis. Experimental Hematology. 39: 986-998.e5. PMID 21726513 DOI: 10.1016/J.Exphem.2011.06.010  0.33
2010 Fung TK, Chung MIS, Liang R, Leung AYH. Role of a novel zebrafish nup98 during embryonic development Experimental Hematology. 38. PMID 20696206 DOI: 10.1016/J.Exphem.2010.07.010  0.337
2007 Fung TK, Ma HT, Poon RY. Specialized roles of the two mitotic cyclins in somatic cells: cyclin A as an activator of M phase-promoting factor. Molecular Biology of the Cell. 18: 1861-73. PMID 17344473 DOI: 10.1091/Mbc.E06-12-1092  0.703
2006 Chan WM, Mak MC, Fung TK, Lau A, Siu WY, Poon RY. Ubiquitination of p53 at multiple sites in the DNA-binding domain. Molecular Cancer Research : McR. 4: 15-25. PMID 16446403 DOI: 10.1158/1541-7786.Mcr-05-0097  0.605
2005 Fung TK, Yam CH, Poon RY. The N-terminal regulatory domain of cyclin A contains redundant ubiquitination targeting sequences and acceptor sites. Cell Cycle (Georgetown, Tex.). 4: 1411-20. PMID 16123593 DOI: 10.4161/Cc.4.10.2046  0.69
2005 Fung TK, Poon RY. A roller coaster ride with the mitotic cyclins. Seminars in Cell & Developmental Biology. 16: 335-42. PMID 15840442 DOI: 10.1016/J.Semcdb.2005.02.014  0.681
2003 Chow JP, Siu WY, Fung TK, Chan WM, Lau A, Arooz T, Ng CP, Yamashita K, Poon RY. DNA damage during the spindle-assembly checkpoint degrades CDC25A, inhibits cyclin-CDC2 complexes, and reverses cells to interphase. Molecular Biology of the Cell. 14: 3989-4002. PMID 14517313 DOI: 10.1091/Mbc.E03-03-0168  0.638
2002 Yam CH, Fung TK, Poon RY. Cyclin A in cell cycle control and cancer. Cellular and Molecular Life Sciences : Cmls. 59: 1317-26. PMID 12363035 DOI: 10.1007/S00018-002-8510-Y  0.716
2002 Fung TK, Siu WY, Yam CH, Lau A, Poon RY. Cyclin F is degraded during G2-M by mechanisms fundamentally different from other cyclins. The Journal of Biological Chemistry. 277: 35140-9. PMID 12122006 DOI: 10.1074/Jbc.M205503200  0.682
Show low-probability matches.